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Taste receptor cells in taste buds detect chemical compounds in foods and drinks and transmit these
signals through gustatory nerve ﬁbers to the central nervous system. Sensory signals of taste are
essential for animal feeding behavior; animals prefer sweet taste and avoid bitter and sour tastes.
Recent studies have demonstrated that the sensitivity of taste receptor cells to tastants is not constant
but is subject to regulation by hormones and bioactive substances, such as leptin and endocannabi-
noids. Leptin selectively suppresses sweet taste sensitivity. In contrast, endocannabinoids selectively
enhance sweet taste sensitivity. Both types of signaling molecules act at their respective receptors in
sweet-sensitive taste cells. In addition, glucagon-like peptide-1 (GLP-1), glucagon, oxytocin, insulin,
cholecystokinin, neuropeptide Y, and vasoactive intestinal peptide (VIP) have been implicated in the
regulation of peripheral taste sensitivity. In this review, the hormones and bioactive substances that
affect peripheral taste sensitivity are summarized. Regulation of peripheral taste sensitivity by
hormones and bioactive substances may play an important role in the control of feeding behavior
and maintenance of energy, ion, and amino acid homeostasis in animals.
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Taste sensation is essential for animal feeding behavior. In general,
sweet, salty, umami, sour, and bitter are considered the basic taste
qualities. Among them, sweet, salty, and umami are preferable and
sour and bitter are aversive stimuli for animals. Taste receptor cells in
taste buds located on the tongue and the palate are dedicated to theciation for Oral Biology. Publisheddetection and transmission of these taste signals. Recently, the
molecular mechanisms underlying the reception and transduction
of taste signals in these cells have been elucidated. Sweet, umami, and
bitter substances activate G-protein coupled receptors (T1R2þT1R3
[1–6] for sweet; T1R1þT1R3 [7,8] for umami; and T2Rs [9] for bitter)
and subsequent common signaling pathways involving gustducin
[10], PLCb2 [11], IP3R3 [12], and TRPM5 [11,13]. Salty and sour
substances are believed to activate channel-type receptors (ENaC
[14,15] and TRPV1t [16] for salty and PKD1L3/2L1 [17,18], ASIC [19],
and HCN [20] for sour). Each of these taste receptors is expressed in a
separate set of taste cells [5,15,17], suggesting that each taste cellby Elsevier B.V. All rights reserved.
Table 1
Hormones and bioactive substances that affect peripheral taste sensitivity.
Function Source Receptor expression
Leptin Sweet k Circulation Sweet-sensitive cells?
Endocannabinoids Sweetm ? Sweet cells (T1R3-expressing cells)
GLP-1 Sweetm, Sourk Type II and Type III cells Gustatory nerve ﬁbers
Glucagon Sweetm Sweet cells (T1R3-expressing cells) Sweet cells (T1R3-expressing cells)
Insulin Saltm Circulation Taste bud cells (not speciﬁed)
CCK Bitterm? Taste cells (bitter cells?) Taste cells (bitter cells?)
Oxytocin ? Circulation Type I cells
NPY ? Taste cells (bitter cells?) Taste bud cells (not speciﬁed)
VIP Sweetk?, Bitterk?, Sourm? Taste cells (bitter cells?) Type II cells (PLCb2-expressing cells)
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respond to a single taste quality, although taste cells tuned to
multiple taste qualities are also present in taste buds [21,22].
Response properties of these taste cells are very similar to those of
gustatory nerve ﬁbers, suggesting that these cells transmit taste
information directly to gustatory nerve ﬁbers without major mod-
iﬁcation [22,23].
Recent studies have revealed that many hormones and bioac-
tive substances modulate peripheral taste sensitivity. Leptin, an
anorexigenic hormone that reduces food intake by acting on
hypothalamic receptors [24], selectively suppresses sweet taste
responses, and these effects may be mediated by the leptin
receptor, Ob–Rb, in sweet taste cells [25–27]. Endocannabinoids,
orexigenic mediators that act via CB1 receptors in the hypothala-
mus and limbic forebrain to induce appetite and stimulate food
intake [28–30], enhance peripheral sweet taste reception [31].
GLP-1, an incretin that inﬂuences glucose transport, metabolism,
and homeostasis [32], typically acts to maintain or enhance sweet
taste sensitivity via paracrine action [33]. Such regulation of
peripheral taste sensitivity by hormones and bioactive substances
may play a role in the control of feeding behavior and the
maintenance of energy, ion, and amino acid homeostasis in
animals. This article summarizes data from recent studies on
the modulation of peripheral taste sensitivity by hormones and
bioactive substances (Table 1).2. Leptin
Leptin was the ﬁrst hormone reported to modulate taste
sensitivity in the peripheral taste organ. Leptin is primarily
produced in adipose cells, and it regulates food intake, energy
expenditure, and body weight mainly via activation of the
hypothalamic leptin receptor Ob–Rb [34–36]. The ﬁrst clue
indicating that leptin affects taste sensitivity was found in the
db/db mouse. db/db mice have leptin receptor defects and are
hyperphagic, massively obese, and diabetic [35,36]. These mice
also show greater gustatory nerve and behavioral responses to
various sweet substances than do lean control mice, but this
effect was not seen in response to salty, bitter, and sour sub-
stances [37,38]. In contrast, streptozotocin-induced diabetic mice
do not exhibit greater sugar responses [37], indicating that the
diabetic state itself does not contribute to greater sensitivity to
sweet substances in db/dbmice. When leptin was administered to
lean control mice, chorda tympani nerve responses and beha-
vioral lick responses to sweet substances were selectively sup-
pressed, and those to sour, salty, and bitter substances were
unaffected [25,26]. In contrast, such selective suppression of
sweet responses by leptin was not observed in db/db mice
[25,26], indicating that the effect of leptin on sweet taste
sensitivity is mediated by the leptin receptor Ob–Rb. Expression
of Ob–Rb was observed in taste bud cells [25,26,39], and theoutward potassium currents of isolated mouse taste cells
increased in the presence of leptin [25], leading to reduced cell
excitability. Indeed, about half of the sweet-responsive cells in
mice showed a signiﬁcant reduction of impulse frequencies in
response to sweet stimuli during leptin application (10–20 ng/mL)
(Yoshida et al. unpublished observation). Thus, leptin reduces the
taste sensitivity of sweet taste cells in mice via Ob–Rb, which is
expressed in these cells.
Leptin also affects sweet taste sensitivity in humans. Circulat-
ing leptin levels show diurnal variation [40,41], with plasma
leptin levels rising before noon and peaking at midnight (2300–
0100) before declining by morning [42]. When the diurnal
patterns of plasma leptin and taste recognition threshold were
measured in healthy adults (men and women aged 21–31 years;
BMI, o25), the recognition threshold for sweet compounds—but
not for salty, bitter, sour, or umami compounds—showed a
diurnal variation that paralleled the variation in plasma leptin
[43]. The diurnal variation of leptin reﬂects meal-related shifts.
For example, when meals were shifted by 6.5 h without changing
the light or sleep cycles in humans, plasma leptin levels similarly
shifted by 5–7 h [44]. The nocturnal rise of leptin did not occur if
the subjects were fasted [45]. When leptin levels were phase-
shifted following the imposition of 1 or 2 meals per day, the
diurnal variation in the recognition threshold for sweet taste
shifted in parallel [43]. These relationships between plasma leptin
concentration and recognition threshold for sweet taste imply a
regulatory role for leptin on human sweet sensitivity.3. Endocannabinoids
The sweet suppressing effect of leptin may be a major reason
why db/db mice show greater responses to sweeteners. However,
it is not clear if the disinhibition of leptin’s effect in db/db mice
alone can lead to the enhancement of sweet taste responses.
Defective leptin signaling is associated with elevated hypothala-
mic levels of endocannabinoids in obese db/db and ob/ob mice
and in Zucker rats [46]. Endocannabinoids such as anandamide
(N-arachidonoylethanolamine [AEA]) and 2-arachidonoyl glycerol
(2-AG) are orexigenic mediators that act via cannabinoid recep-
tors (CB1) in the hypothalamus and limbic forebrain to increase
appetite [28,29] and stimulate food intake [30]. Circulating
endocannabinoid levels are inversely correlated with plasma
levels of leptin [47]. These pieces of evidence raise the possibility
that endocannabinoids may oppose the effects of leptin on sweet
taste sensitivity. When wild-type mice were given AEA or 2-AG
intraperitoneally, gustatory nerve responses and behavioral
responses to sweet substances enhanced without changes in
responses to salty, sour, bitter, and umami substances [31]. This
effect was not observed in CB1 knockout (KO) mice, suggesting
that endocannabinoids selectively enhance sweet taste sensitivity
via the CB1 receptor. At the peripheral taste cell level, basolateral
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sensitive taste cells, and this effect was inhibited by AM251, a CB1
receptor antagonist, but not by AM630, a CB2 receptor antagonist
[31]. In addition, approximately 60% of taste cells expressing
T1R3, a sweet receptor component, co-expressed CB1. Thus,
endocannabinoids enhance sweet taste sensitivity by acting on
CB1 receptors in sweet-sensitive taste cells.
Returning to the ﬁrst problem, do endocannabinoids contri-
bute to enhanced sweet responses in db/db mice? When db/db
mice were administered AM251, gustatory nerve responses to
sweeteners but not to salty, bitter, sour, and umami compounds
decreased to levels similar to those shown by wild-type mice,
indicating that enhanced sweet taste responses disappeared in
db/db mice following the administration of a CB1 blocker (Ohkuri
et al. unpublished observation). Therefore, enhanced sweet taste
responses in db/dbmice may occur through the tonic activation of
the CB1 receptor by endocannabinoids. However, the source of
endocannabinoids is still unclear because of the difﬁculty in
measuring endocannabinoids in taste tissues and circulation.4. Glucagon-like peptide-1
Glucagon-like peptide-1 (GLP-1) is secreted from intestinal
endocrine L-cells and regulates many physiological processes
such as pancreatic insulin secretion and biosynthesis, feeding
behavior, gastric motility, glucoregulation, and cardiovascular
function via the central and peripheral nervous systems. GLP-1
also inﬂuences gastric emptying, gastric acid secretion, and
cardiac contractility [48]. In human intestinal endocrine L cells,
taste-signaling elements such as T1R2, T1R3, gustducin, PLCb2,
and TRPM5 are co-expressed with GLP-1 [49]. These taste-signal-
ing elements mediate the glucose-dependent secretion of GLP-1
from the enteroendocrine L-cells of the gut [49]. Because of the
cellular co-expression of and functional relationship between
GLP-1, T1R3, and gustducin in the gut, it was hypothesized that
these molecules may also function together in the peripheral
gustatory system [33]. In mouse taste buds, GLP-1 was found to
be expressed in a subset of T1R3-expressing cells, which may be
sweet and/or umami taste receptor cells, and a subset of 5-HT
expressing (Type III) taste cells, which may be sour taste receptor
cells. The GLP-1 receptor is expressed on intragemmal nerve
ﬁbers in mouse taste buds. These lines of evidence suggest that
GLP-1 may be released from sweet, umami, and/or sour taste cells
and may activate the GLP-1 receptor on gustatory nerve ﬁbers.
Compared to wild-type mice, GLP-1 receptor KO mice showed
markedly reduced behavioral responses to sweeteners, indicating
that GLP-1 signaling typically acts to maintain or enhance sweet
taste sensitivity. In addition, a modest increase in citric acid taste
sensitivity was observed in GLP-1 receptor KO mice, suggesting
that GLP-1 signaling may modulate sour taste as well.5. Glucagon
Glucagon is secreted from the a cells of pancreatic islets in
response to hypoglycemia [50]. The major biological action of
glucagon is the regulation of glucose homeostasis via the liver.
Liver cells express the glucagon receptor (GlucR) and binding of
glucagon signals both glycogenolysis, which is the conversion of
glycogen polymers to glucose monomers, and gluconeogenesis,
which is the generation of glucose from non-carbohydrate carbon
substrates [50]. GlucRs are also expressed in islet b cells and may
contribute to the regulation of glucose-stimulated insulin secre-
tion [51]. GLP-1 and glucagon are both derived from proglucagon,
which is encoded by the gene GCG. Given that GLP-1 modulatestaste sensitivity and that glucagon is expressed in a subset of taste
cells, researchers examined the role of glucagon signaling in taste
sensitivity [52]. In mouse taste buds, glucagon and GlucR are
expressed in overlapping subsets of taste bud cells, and these cells
express PLCb2 and T1R3 but not 5-HT, indicating that sweet and/
or umami taste cells express both glucagon and GlucR. To produce
mature glucagon, the chaperone protein 7B2 is required for the
activation of PC2, which is an enzyme for cleaving glucagon from
proglucagon [53]. Mice lacking the Scg5 gene encoding 7B2
showed no glucagon staining in their taste bud cells. These
Scg5/ mice also had lower behavioral sensitivity to sweet but
not salty, bitter, and sour compounds than did wild-type mice.
Further, short-term local (oral) application of L-168-049, a highly
speciﬁc, membrane-permeable GlucR antagonist, reduced beha-
vioral responses to sweet but not salty, bitter, and sour com-
pounds in mice. Thus, glucagon may also enhance or maintain
sweet taste responsiveness in mice.6. Insulin
Insulin is secreted from the pancreatic b cells in the islets of
Langerhans and regulates carbohydrate and fat metabolism. A
recent study demonstrated that insulin may affect salt sensitivity
in mice [54]. In mice, the epithelial sodium channel (ENaC) is
believed to be a receptor for salty taste [14,15]. Insulin is known
to increase the open probability of ENaC [55] and the expression
of ENaC in the cell membrane [56]. When insulin was adminis-
tered to isolated fungiform taste bud cells, the Naþ current
increased [54]. This Naþ current was sensitive to amiloride and/
or benzamil, which are both inhibitors of ENaC, suggesting that
insulin activates ENaC in taste bud cells. The enhancement of
ENaC function by insulin in taste bud cells was mediated by both
phosphoinositide 3-kinase OH (PI3-kinase) signaling pathway and
PI4-kinase signaling pathway, because this effect was suppressed
by pharmacological blockers of these kinases, such as LY294002,
and wortmannin. In preference tests, insulin-treated mice showed
signiﬁcant avoidance of NaCl solutions at lower concentrations
than did the control mice, and this effect of insulin was abolished
by the addition of amiloride to the NaCl solutions. These data
indicate that insulin may enhance salt taste sensitivity in mice via
amiloride-sensitive (ENaC-expressing), salt-sensitive taste cells.7. Cholecystokinin
Cholecystokinin (CCK) is secreted from enteroendocrine I-cells
and stimulates gastric emptying in addition to the secretion of
digestive enzymes and bile from the pancreas and gallbladder.
It was reported that CCK and one of its receptors, CCK-1, are
expressed in a subset of taste bud cells [57–59]. In the circum-
vallate taste buds of rats, 50–60% of CCK-positive cells expressed
a-gustducin and 15% of them expressed T1R2 [58]. In the poster-
ior tongue, members of the T2R family are co-expressed with
gustducin whereas T1Rs are mostly segregated from gustducin
[60,61]. Therefore, the majority of CCK-positive cells may be
bitter-sensitive taste cells. The expression of the CCK-1 receptor
in taste buds completely overlaps with that of CCK [59], indicating
that CCK may function in an autocrine manner in taste buds. The
physiological function of CCK in taste bud cells was also investi-
gated [57]. Exogenous application of CCK to isolated rat taste bud
cells in the posterior tongue inhibited the outward Kþ current
and induced Ca2+ responses, and these effects were suppressed by
lorglumide (speciﬁc inhibitor of CCK-1 over CCK-2 receptors) but
not by L-365-260 (CCK-2 inhibitor). Many CCK-sensitive cells
showed Ca2þ responses to bitter taste stimuli, such as quinine
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sensitivity of taste cells.8. Oxytocin
Oxytocin is a nonapeptide hormone that stimulates parturition
and lactation [62]. It also plays key roles in the regulation of
complex social behavior and cognition, such as attachment, social
exploration, recognition, and aggression [63]. In addition, oxyto-
cin has potent central effects on feeding behavior [64]. Oxytocin
KO mice overconsume solutions of saccharin and carbohydrates
[65] and show enhanced consumption of NaCl solution after ﬂuid
deprivation [66]. Thus, oxytocin may inﬂuence sensitivity to
sweet and salty compounds via the peripheral taste system, but
this hypothesis was challenged by Sinclair et al. [67] Using
RT-PCR, oxytocin receptor (OXTR) mRNA was detected in fungi-
form, circumvallate, foliate, and palate taste buds. In OXTR-YFP
knock-in mice, which express the Venus variant of yellow
ﬂuorescent protein (YFP) in OXTR-expressing cells, YFP expres-
sion was observed in a subset of taste bud cells that express
NTPDase2, which is a Type I cell marker. PLCb2-expressing cells
(Type II cells) and chromogranin A-expressing cells (Type III cells)
did not express OXTR-YFP. This was conﬁrmed by single-cell RT-
PCR; several NTPDase2-positive cells expressed OXTR. Taste bud
cells and their associated nerves did not contain the oxytocin
peptide itself, suggesting that oxytocin may access taste cells
from the blood ﬂowing to the taste organ or possibly from saliva.
The application of oxytocin to isolated taste bud cells induced
Ca2þ responses in a subset of taste bud cells, and these responses
were inhibited by the OXTR antagonist L-371-257, suggesting that
oxytocin actually affects a subset of taste bud cells (probably Type
I cells) via OXTR. However, it is not clear whether this oxytocin
effect on taste bud cells actually inﬂuences the sensitivity of taste
receptor cells.9. Neuropeptide Y
Neuropeptide Y (NPY) is a 36-amino acid neuropeptide and
has been implicated in the regulation of many physiological
processes such as blood pressure, food intake, seizure, anxiety,
bone formation, pain sensation, and emotion [68]. In taste buds,
a subset of taste bud cells express NPY, and these cells virtually
always co-express CCK [69], suggesting that NPY-expressing cells
may be bitter sensitive. When NPY was administered to isolated
taste bud cells, inward rectifying Kþ currents were enhanced in
about one-third of the isolated taste cells tested. Because inward
rectifying Kþ channels contribute to the resting potential and
enhancement of this current would result in hyperpolarization, a
subset of taste bud cells may become less responsive to sensory
stimulation by NPY. The effect of NPY may be mediated by
the NPY-1 receptor given that an NPY-1-speciﬁc antagonist,
BIBP3226, suppressed enhancement of inward rectifying Kþ
currents produced by NPY and the NPY-1 agonist [Leu-31, Pro-
34]–NPY. The NPY-1 receptor is expressed in a small subset of
taste bud cells and is more widely expressed in the basal layer of
the lingual epithelium [70]. NPY-1 receptor expressing cells in
taste buds have not been characterized, and the function of NPY
in the peripheral taste system is unknown.10. Vasoactive intestinal peptide
Vasoactive intestinal peptide (VIP), a peptide hormone com-
prising 29 amino acid residues, contributes to many physiological
functions such as metabolism, exocrine/endocrine secretion, celldifferentiation, smooth muscle relaxation, and immunity. VIP is
found in the taste buds [59]. Similar to CCK, many (about 60%)
VIP-positive cells co-express gustducin and a few (about 20%) co-
express T1R2 in the circumvallate papillae of rats. In addition,
both CCK and VIP are expressed in almost identical subsets of
taste bud cells. Therefore, VIP-expressing cells may also be bitter
sensitive since the majority of CCK-positive cells may be bitter
sensitive. There is no direct evidence indicating that VIP affects
the sensitivity of taste receptor cells, although a recent study
demonstrated that receptors for VIP (VPAC1 and VPAC2) were
expressed in Type II cells (PLCb2-expressing cells) [39]. That
study also reported that VIP-KO mice showed decreased expres-
sion of leptin receptors and increased expression of GLP-1 in
addition to enhanced sweet and bitter sensitivity but decreased
sour sensitivity. Thus, VIP may signal taste receptor cells to
regulate sweet, bitter, and sour taste sensitivity.11. Conclusions
Most of the hormones and bioactive substances summarized in
this paper contribute to the regulation of food intake and energy
homeostasis via both central and peripheral mechanisms. How-
ever, the regulation of taste sensitivity by these compounds at the
taste epithelium may be a critical function underlying the control
of feeding behavior and the maintenance of energy, ion and
amino acid homeostasis in animals. There is no doubt that this
list of modulatory substances will expand in the near future.
Although these hormones and bioactive substances may affect
peripheral taste sensitivity, the physiological outcomes of such
regulation may be notably different among various hormones and
bioactive compounds. For instance, leptin, oxytocin, and insulin
access the epithelium from circulation, suggesting that the
regulation of taste sensitivity by these substances may be highly
dependent on the systemic requirements of an individual (e.g.,
nutritional state, body composition). In contrast, GLP-1, glucagon,
CCK, NPY, and VIP are present in taste bud cells and may function
locally in an autocrine and/or a paracrine fashion, suggesting that
these substances may be used for local cell–cell communication
or for intracellular regulation of the taste bud itself.Conﬂict of interest
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